NDC 51407-172

Atazanavir Sulfate

Atazanavir Sulfate

Atazanavir Sulfate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Golden State Medical Supply Inc.. The primary component is Atazanavir Sulfate.

Product ID51407-172_7d3dded0-ccd0-6cfc-e053-2991aa0a22f9
NDC51407-172
Product TypeHuman Prescription Drug
Proprietary NameAtazanavir Sulfate
Generic NameAtazanavir Sulfate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2017-12-27
Marketing CategoryANDA / ANDA
Application NumberANDA091673
Labeler NameGolden State Medical Supply Inc.
Substance NameATAZANAVIR SULFATE
Active Ingredient Strength200 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51407-172-60

60 CAPSULE in 1 BOTTLE (51407-172-60)
Marketing Start Date2017-12-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51407-172-60 [51407017260]

Atazanavir Sulfate CAPSULE
Marketing CategoryANDA
Application NumberANDA091673
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-12-27

Drug Details

Active Ingredients

IngredientStrength
ATAZANAVIR SULFATE200 mg/1

OpenFDA Data

SPL SET ID:7d3f6d18-446f-0fff-e053-2a91aa0a6edd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 664741
  • 402246
  • 402247
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • UGT1A1 Inhibitors [MoA]
    • UDP Glucuronosyltransferases Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]
    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • UGT1A1 Inhibitors [MoA]
    • UDP Glucuronosyltransferases Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]

    NDC Crossover Matching brand name "Atazanavir Sulfate" or generic name "Atazanavir Sulfate"

    NDCBrand NameGeneric Name
    0093-5526Atazanavir SulfateAtazanavir Sulfate
    0093-5527Atazanavir SulfateAtazanavir Sulfate
    0093-5528Atazanavir SulfateAtazanavir Sulfate
    0904-6875Atazanavir SulfateAtazanavir
    16714-860Atazanavir SulfateAtazanavir
    16714-861Atazanavir SulfateAtazanavir
    16714-862Atazanavir SulfateAtazanavir
    51407-171Atazanavir SulfateAtazanavir Sulfate
    51407-172Atazanavir SulfateAtazanavir Sulfate
    51407-173Atazanavir SulfateAtazanavir Sulfate
    60687-399Atazanavir SulfateAtazanavir
    65862-710Atazanavir SulfateAtazanavir
    65862-711Atazanavir SulfateAtazanavir
    65862-712Atazanavir SulfateAtazanavir
    65862-713Atazanavir SulfateAtazanavir
    70518-1365Atazanavir SulfateAtazanavir Sulfate
    70518-0946Atazanavir SulfateAtazanavir Sulfate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.